CSPC Pharmaceutical Group Limited (CSPCY)
USD 3.05
(-2.71%)
USD 3.05
(-2.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 31.45 Billion | 30.93 Billion | 27.86 Billion | 24.94 Billion | 22.1 Billion | 18.46 Billion |
| Cost of Revenue | 9.27 Billion | 8.68 Billion | 6.73 Billion | 6.25 Billion | 6.19 Billion | 6.24 Billion |
| Gross Profit | 22.17 Billion | 22.25 Billion | 21.13 Billion | 18.68 Billion | 15.91 Billion | 12.21 Billion |
| Operating Expenses | 15.19 Billion | 15.49 Billion | 14.34 Billion | 12.62 Billion | 11.31 Billion | 8.23 Billion |
| Selling, General and Administrative Expenses | 10.33 Billion | 11.51 Billion | 11.45 Billion | 10.32 Billion | 9.46 Billion | 7.12 Billion |
| Research and Development Expenses | 4.86 Billion | 3.98 Billion | 3.43 Billion | 2.88 Billion | 2 Billion | 1.39 Billion |
| Other Expenses | - | 814.84 Million | 545.69 Million | - | - | 181.19 Million |
| Cost and Expenses | 24.46 Billion | 24.17 Billion | 21.07 Billion | 18.88 Billion | 17.5 Billion | 14.48 Billion |
| Operating Income | 6.98 Billion | 7.55 Billion | 6.81 Billion | 6.07 Billion | 4.6 Billion | 3.97 Billion |
| Interest Expense | 25.89 Million | 24.89 Million | 7.66 Million | 12.23 Million | 32.42 Million | 76.9 Million |
| Income Tax Expense | 1.31 Billion | 1.35 Billion | 1.15 Billion | 1.16 Billion | 892.81 Million | 766.7 Million |
| Earnings before Tax | 7.38 Billion | 7.58 Billion | 6.84 Billion | 6.39 Billion | 4.62 Billion | 3.95 Billion |
| Net Income | 5.87 Billion | 6.09 Billion | 5.6 Billion | 5.15 Billion | 3.71 Billion | 3.08 Billion |
| Earnings Per Share Basic | 0.49 | 2.04 | 1.88 | 1.73 | 1.24 | - |
| Earnings Per Share Diluted | 0.49 | 2.04 | 1.88 | 1.73 | 1.24 | - |
| Weighted Average Shares Outstanding | 11.87 Billion | 2.97 Billion | 2.98 Billion | 2.98 Billion | 2.98 Billion | - |
| Weighted Average Shares Outstanding (Diluted) | 11.87 Billion | 2.97 Billion | 2.98 Billion | 2.98 Billion | 2.98 Billion | - |
| Gross Margin | 0.71 | 0.72 | 0.76 | 0.75 | 0.72 | 0.66 |
| EBIT Margin | 0.27 | 0.28 | 0.28 | 0.28 | 0.24 | 0.22 |
| Profit Margin | 0.19 | 0.20 | 0.20 | 0.21 | 0.17 | 0.17 |
| EBITDA | 8.53 Billion | 8.65 Billion | 7.72 Billion | 7.21 Billion | 5.35 Billion | 4.49 Billion |
| Earnings Before Tax Margin | 0.22 | 0.24 | 0.24 | 0.24 | 0.21 | 0.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.3 Billion | 8.98 Billion | 31.45 Billion | 7.58 Billion | 7.78 Billion | 8.02 Billion |
| Cost of Revenue | 2.14 Billion | 2.48 Billion | 9.27 Billion | 2.2 Billion | 2.23 Billion | 2.3 Billion |
| Gross Profit | 5.15 Billion | 6.49 Billion | 22.17 Billion | 5.38 Billion | 5.55 Billion | 5.71 Billion |
| Operating Expenses | 3.49 Billion | 4.46 Billion | 15.16 Billion | 3.59 Billion | 3.76 Billion | 4.02 Billion |
| Selling, General and Administrative Expenses | 2.11 Billion | 3.29 Billion | - | 2.44 Billion | 2.44 Billion | 2.68 Billion |
| Research and Development Expenses | 1.37 Billion | 1.16 Billion | - | 1.15 Billion | 1.37 Billion | 1.29 Billion |
| Other Expenses | - | - | 420.59 Million | 14.71 Million | 136.93 Million | 210.43 Million |
| Cost and Expenses | 5.63 Billion | 6.94 Billion | 24.43 Billion | 5.79 Billion | 6 Billion | 6.32 Billion |
| Operating Income | 1.66 Billion | 2.03 Billion | 7.71 Billion | 1.96 Billion | 1.93 Billion | 1.9 Billion |
| Interest Expense | - | - | 25.89 Million | 9.01 Million | 6.15 Million | 6.29 Million |
| Income Tax Expense | 321.31 Million | 428.35 Million | 1.31 Billion | 351.93 Million | 341.22 Million | 311.65 Million |
| Earnings before Tax | 1.74 Billion | 2.05 Billion | 7.38 Billion | 1.77 Billion | 1.92 Billion | 1.9 Billion |
| Net Income | 1.4 Billion | 1.61 Billion | 5.87 Billion | 1.37 Billion | 1.52 Billion | 1.53 Billion |
| Earnings Per Share Basic | 0.12 | 0.14 | - | 0.13 | 0.14 | 0.14 |
| Earnings Per Share Diluted | 0.12 | 0.14 | - | 0.13 | 0.14 | 0.14 |
| Weighted Average Shares Outstanding | 11.82 Billion | 11.85 Billion | 2.96 Billion | 11.85 Billion | 11.85 Billion | 11.86 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.82 Billion | 11.85 Billion | 2.96 Billion | 11.85 Billion | 11.85 Billion | 11.86 Billion |
| Gross Margin | 0.71 | 0.72 | 0.71 | 0.71 | 0.71 | 0.71 |
| EBIT Margin | 0.27 | 0.25 | - | 0.24 | 0.25 | 0.24 |
| Profit Margin | 0.19 | 0.18 | 0.19 | 0.18 | 0.20 | 0.19 |
| EBITDA | 1.94 Billion | 2.26 Billion | - | 1.78 Billion | 1.93 Billion | 1.9 Billion |
| Earnings Before Tax Margin | 0.23 | 0.23 | 0.25 | 0.26 | 0.25 | 0.24 |
UPBD
SZHIF
RDBBF
ARG
PT
ASMXF